Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results. (Q48513003)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results. |
scientific article |
Statements
1 reference
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results. (English)
1 reference
Henry S Friedman
1 reference
Darell D Bigner
1 reference
Sridharan Gururangan
1 reference
Annick Desjardins
1 reference
Allan H Friedman
1 reference
David A Reardon
1 reference
Roger E McLendon
1 reference
Jeremy N Rich
1 reference
R Edward Coleman
1 reference
Jennifer A Quinn
1 reference
James J Vredenburgh
1 reference
James E Herndon
1 reference
James M Provenzale
1 reference
Jeannette M Dowell
1 reference
Michael A Badruddoja
1 reference
Michael R Zalutsky
1 reference
Gamal Akabani
1 reference
Charles N Pegram
1 reference
Xiao-Guang Zhao
1 reference
John H Sampson
1 reference
Terence Z Wong
1 reference
1 June 2006
1 reference
1 reference
47
1 reference
6
1 reference
912-918
1 reference
Identifiers
1 reference